Crossmark

Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study

Crossref DOI link: https://doi.org/10.1007/s00044-022-02970-3

Published Online: 2022-12-29

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rabie, Amgad M. http://orcid.org/0000-0003-3681-114X
Abdalla, Mohnad http://orcid.org/0000-0002-1682-5547
License Information

Text and Data Mining valid from 2022-12-29

Version of Record valid from 2022-12-29
More Information

Article History

Received: 3 June 2022

Accepted: 6 September 2022

First Online: 29 December 2022

Compliance with Ethical Standards

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below